![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Igraine Plc - Fixit Medical Ltd Receipt of Grant from Innovate UK PR Newswire LONDON, United Kingdom, July 03 THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO...
Igraine Plc - Financial Statements to 31 December 2023 PR Newswire LONDON, United Kingdom, June 25 Financial Statements for the Year Ended 31 December 2023 Igraine Plc(“Igraine” or “the...
don-based healthcare and life-science investor - Says Fixit Medical Ltd has "made significant progress" towards commer ...
G THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE REGULATION (EU) NO. 596/2014, AS AMENDED...
The following is a round-up of earnings by London-listed companies, issued last week and not separately reported by A ...
G The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as amended by The...
G Igraine plc (AQSE:KING), an investing company focused on breakthrough innovative technologies and discoveries in the healthcare and life sciences sectors, has received 2 TR-1 Forms, which are...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0.275 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0.275 | 0 | 0 | 0 | DE |
12 | -0.025 | -8.33333333333 | 0.3 | 0.3 | 0.2 | 27988 | 0.3 | DE |
26 | -0.025 | -8.33333333333 | 0.3 | 0.35 | 0.2 | 56317 | 0.3 | DE |
52 | 0 | 0 | 0.275 | 0.35 | 0.1525 | 151960 | 0.29354588 | DE |
156 | -2.1 | -88.4210526316 | 2.375 | 2.5 | 0.05 | 667576 | 1.27548687 | DE |
260 | -2.1 | -88.4210526316 | 2.375 | 2.5 | 0.05 | 667576 | 1.27548687 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions